Alexander Endler Selected Research

Prokaryotic Initiation Factor-3

1/2016

Silencing of eIF3e promotes blood perfusion recovery after limb ischemia through stabilization of hypoxia-inducible factor 2α activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Endler Research Topics

Disease

6	Hypoxia (Hypoxemia) 01/2016 - 04/2007
1	Coronary Disease (Coronary Heart Disease) 12/2019
1	Pre-Eclampsia (Preeclampsia) 12/2018
1	Ischemia 01/2016
1	Myocardial Infarction 12/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2007
1	Neoplasms (Cancer) 04/2007
1	Breast Neoplasms (Breast Cancer) 04/2007
1	Brain Ischemia (Cerebral Ischemia) 04/2007

Drug/Important Bio-Agent (IBA)

2	endothelial PAS domain-containing protein 1IBA 08/2010 - 04/2007
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2018
1	arginine methyl esterIBA 12/2018
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2018
1	Prokaryotic Initiation Factor-3IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2013
1	Interleukin-8 (Interleukin 8)IBA 04/2013
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 04/2012
1	Estrogen ReceptorsIBA 04/2012
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	DNA (Deoxyribonucleic Acid)IBA 04/2007
1	MutagensIBA 04/2007

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2019
1	Intramuscular Injections 01/2016
1	Therapeutics 12/2009